Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean
Clinical trial NCT04218162 · COMPLETED
Trial details
- NCT number
- NCT04218162
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-24
- Primary completion
- 2020-10-30
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.